Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1

Matrine may be protective against colorectal cancer (CRC), but how it may work is unclear. Thus, we explored the underlying mechanisms of matrine in CRC. Matrine-related proteins and CRC-related genes and therapeutic targets of matrine in CRC were predicted using a network pharmacology approach. Fiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Huizhen Fan, Chunyan Jiang, Baoyuan Zhong, Jianwen Sheng, Ting Chen, Qingqing Chen, Jingtao Li, Hongchuan Zhao
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/5408324
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561975983341568
author Huizhen Fan
Chunyan Jiang
Baoyuan Zhong
Jianwen Sheng
Ting Chen
Qingqing Chen
Jingtao Li
Hongchuan Zhao
author_facet Huizhen Fan
Chunyan Jiang
Baoyuan Zhong
Jianwen Sheng
Ting Chen
Qingqing Chen
Jingtao Li
Hongchuan Zhao
author_sort Huizhen Fan
collection DOAJ
description Matrine may be protective against colorectal cancer (CRC), but how it may work is unclear. Thus, we explored the underlying mechanisms of matrine in CRC. Matrine-related proteins and CRC-related genes and therapeutic targets of matrine in CRC were predicted using a network pharmacology approach. Five targets, including interleukin 6 (IL-6), the 26S proteasome, tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β1) and p53, and corresponding high-mobility group box 1 (HMGB1) signaling and T helper cell differentiation were thought to be associated with matrine’s mechanism. Expression of predicted serum targets were verified in a 1,2-dimethylhydrazine dihydrochloride-induced CRC model rats that were treated with matrine (ip) for 18 weeks. Data show that matrine suppressed CRC growth and decreased previously elevated expression of IL-6, TNF-α, p53, and HMGB1. Matrine may have had a therapeutic effect on CRC via inhibition of HMGB1 signaling, and this occurred through downregulation of IL-6, TNF-α, and HMGB1.
format Article
id doaj-art-5b2e56634b2a4d69a89cca345fdda6e4
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-5b2e56634b2a4d69a89cca345fdda6e42025-02-03T01:23:43ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/54083245408324Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1Huizhen Fan0Chunyan Jiang1Baoyuan Zhong2Jianwen Sheng3Ting Chen4Qingqing Chen5Jingtao Li6Hongchuan Zhao7Department of Gastroenterology, The People’s Hospital of Yichun City, Yichun, ChinaDepartment of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Beijing, ChinaDepartment of General Surgery, First Affiliated Hospital of Gannan Medical College, Ganzhou, ChinaDepartment of Gastroenterology, The People’s Hospital of Yichun City, Yichun, ChinaDepartment of Gastroenterology, The People’s Hospital of Yichun City, Yichun, ChinaDepartment of Gastroenterology, The People’s Hospital of Yichun City, Yichun, ChinaDepartment of Gastroenterology, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Gastroenterology, China-Japan Friendship Hospital, Beijing, ChinaMatrine may be protective against colorectal cancer (CRC), but how it may work is unclear. Thus, we explored the underlying mechanisms of matrine in CRC. Matrine-related proteins and CRC-related genes and therapeutic targets of matrine in CRC were predicted using a network pharmacology approach. Five targets, including interleukin 6 (IL-6), the 26S proteasome, tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β1) and p53, and corresponding high-mobility group box 1 (HMGB1) signaling and T helper cell differentiation were thought to be associated with matrine’s mechanism. Expression of predicted serum targets were verified in a 1,2-dimethylhydrazine dihydrochloride-induced CRC model rats that were treated with matrine (ip) for 18 weeks. Data show that matrine suppressed CRC growth and decreased previously elevated expression of IL-6, TNF-α, p53, and HMGB1. Matrine may have had a therapeutic effect on CRC via inhibition of HMGB1 signaling, and this occurred through downregulation of IL-6, TNF-α, and HMGB1.http://dx.doi.org/10.1155/2018/5408324
spellingShingle Huizhen Fan
Chunyan Jiang
Baoyuan Zhong
Jianwen Sheng
Ting Chen
Qingqing Chen
Jingtao Li
Hongchuan Zhao
Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1
Journal of Immunology Research
title Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1
title_full Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1
title_fullStr Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1
title_full_unstemmed Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1
title_short Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1
title_sort matrine ameliorates colorectal cancer in rats via inhibition of hmgb1 signaling and downregulation of il 6 tnf α and hmgb1
url http://dx.doi.org/10.1155/2018/5408324
work_keys_str_mv AT huizhenfan matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT chunyanjiang matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT baoyuanzhong matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT jianwensheng matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT tingchen matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT qingqingchen matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT jingtaoli matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1
AT hongchuanzhao matrineamelioratescolorectalcancerinratsviainhibitionofhmgb1signalinganddownregulationofil6tnfaandhmgb1